| Marchiafava-Bignami disease | |
|---|---|
| Classification and external resources | |
| ICD-10 | G37.1 |
| ICD-9 | 341.8 |
| DiseasesDB | 31494 |
| eMedicine | neuro/204 |
| MeSH | D054319 |
Marchiafava-Bignami disease is a progressive neurological disease characterized by corpus callosum demyelination and necrosis and subsequent atrophy.
|
Contents
|
It was first described in 1903 by the Italian pathologists Amico Bignami and Ettore Marchiafava in an Italian Chianti drinker.[1][2] In this patient, Marchiafava and Bignami noticed that the middle two-thirds of the corpus callosum were necrotic.
It is classically associated with chronic alcoholics and sometimes nutritional deficiencies.
| This article about a disease, disorder, or medical condition is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)